 derive one which encompasses the full natural history and spectrum of HIV disease, and incorporate HIV-RNA as a predictor of disease progression. They will incorporate into the model data from randomized trials of combination antiretroviral therapy as well as from recent OI prophylaxis trials. Using this expanded model and up-to-date clinical,
derive one which encompasses the full natural history and spectrum of HIV disease, and integrate HIV - RNA as a forecaster of disease progress. They will incorporate into the exemplar datum from randomized trials of combination antiretroviral therapy as well as from recent OI prophylaxis trial. Using this expanded exemplar and up - to - date clinical,
 degive one which encompassts the full naturco histmry ans spectrjm of HIV disease, and incorplrqte HUV-RNA as a predictor ow disease progreswion. Rhey will mhcorporate infl thz nodel data frok randomizad trials of cmmciuation antiretroviral therapy as welj as frpm recent OI prokhylaqif trjals. Using this expanded model and up-to-daue clinical,
derive one which encompasses the full natural spectrum HIV disease, incorporate HIV-RNA as They incorporate into the data from randomized of combination antiretroviral therapy as well from recent OI prophylaxis trials. Using this expanded model and up-to-date clinical,
 derive one which encompasses The full natUral hIstOry AnD speCtruM of HIV disease, aND incOrporate HIV-RNA as a prediCtor oF dISeasE PrOgresSion. TheY WiLL IncOrPoRatE iNTo The moDel Data froM randomizeD trIaLs of combinatIOn AntiretrovIraL therapy as weLl aS from rEcEnt oi propHylAxis tRials. USIng thiS expanded MoDEl and uP-To-date cLINiCal,
 derive one which encompas ses the fu ll na tur alhi stor y an d spectrum ofH IV d isease, and incorporat e HIV -R N A as apredi ctor of di s e ase  p ro gre ss i on . The y w ill inc orporate i nto  t he model dat a  f rom random ize d trials ofcom binati on  an t iretr ovi ral t herapy as wel l as from  r e cent O I  prophy l a xi s tr ials. Using thise xp a nded model and  up-to -d a te c lin ica l,
 derive_one which_encompasses the full natural_history and_spectrum_of HIV_disease,_and incorporate HIV-RNA_as a predictor_of disease progression. They_will incorporate into_the_model data from randomized trials of combination antiretroviral therapy as well as from recent_OI_prophylaxis trials._Using_this_expanded model and up-to-date clinical,